Cargando…

Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis

Detalles Bibliográficos
Autores principales:	Lorente, Leonardo, Martín, María M, Solé-Violán, Jordi, Blanquer, José, Páramo, José Antonio
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875491/ https://www.ncbi.nlm.nih.gov/pubmed/20092609 http://dx.doi.org/10.1186/cc8211

Ejemplares similares

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009)

Association between Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels and Mortality in Patients with Severe Brain Trauma Injury
por: Lorente, Leonardo, et al.
Publicado: (2014)

Influence of TIMP-1/MMP-9 ratio on the severity and mortality in sepsis
por: Lorente, L, et al.
Publicado: (2010)

Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction
por: Lorente, Leonardo, et al.
Publicado: (2015)

Influence of TIMP-1/MMP-9 ratio on the severity and mortality in sepsis
por: Lorente, L, et al.
Publicado: (2011)

The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis
por: Lorente, Leonardo, et al.
Publicado: (2013)

Association of Sepsis-Related Mortality with Early Increase of TIMP-1/MMP-9 Ratio
por: Lorente, Leonardo, et al.
Publicado: (2014)

High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients
por: Lorente, Leonardo, et al.
Publicado: (2019)

Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?
por: Hoffmann, Ursula, et al.
Publicado: (2009)

Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis
por: Lorente, Leonardo, et al.
Publicado: (2011)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis
por: Lorente, Leonardo, et al.
Publicado: (2015)

Prognostic Value of Malondialdehyde Serum Levels in Severe Sepsis: A Multicenter Study
por: Lorente, Leonardo, et al.
Publicado: (2013)

The 372 T/C genetic polymorphism of TIMP-1 as a biomarker of mortality in patients with sepsis
por: Lorente, Leonardo, et al.
Publicado: (2013)

Severe Septic Patients with Mitochondrial DNA Haplogroup JT Show Higher Survival Rates: A Prospective, Multicenter, Observational Study
por: Lorente, Leonardo, et al.
Publicado: (2013)

Epidemiology and outcome of patients with severe sepsis in six Spanish ICUs
por: Lorente, L, et al.
Publicado: (2009)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Survival and mitochondrial function in septic patients according to mitochondrial DNA haplogroup
por: Lorente, Leonardo, et al.
Publicado: (2012)

Higher platelet cytochrome oxidase specific activity in surviving than in non-surviving septic patients
por: Lorente, Leonardo, et al.
Publicado: (2014)

Genomic variations within matrix metalloproteinase-9 and severe sepsis
por: Chen, Q, et al.
Publicado: (2009)

Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients
por: Lorente, Leonardo, et al.
Publicado: (2016)

Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury
por: Lorente, Leonardo, et al.
Publicado: (2015)

Elevated Plasma Levels of Matrix Metalloproteinase-3 and Tissue-Inhibitor of Matrix Metalloproteinases-1 Associate With Organ Dysfunction and Mortality in Sepsis
por: Jones, Tiffanie K., et al.
Publicado: (2022)

Lower platelet mitochondrial function in severe septic patients than in controls
por: Lorente, L, et al.
Publicado: (2015)

Matrix metalloproteinases and their inhibitors in pediatric severe acute pancreatitis
por: Vitale, David S., et al.
Publicado: (2022)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2020)

Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study
por: Lorente, Leonardo, et al.
Publicado: (2014)

Sustained high serum malondialdehyde levels are associated with severity and mortality in septic patients
por: Lorente, Leonardo, et al.
Publicado: (2013)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury
por: Lorente, Leonardo, et al.
Publicado: (2015)

Should central venous catheter be systematically removed in patients with suspected catheter related infection?
por: Lorente, Leonardo, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
por: Bektan Kanat, Bahar, et al.
Publicado: (2023)

Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury
por: Lorente, Leonardo, et al.
Publicado: (2015)

Sustained Low Serum Substance P Levels in Non-Surviving Septic Patients
por: Lorente, Leonardo, et al.
Publicado: (2017)

Serum Levels of Substance P and Mortality in Patients with a Severe Acute Ischemic Stroke
por: Lorente, Leonardo, et al.
Publicado: (2016)

[Translated article] Oxygen therapy. Considerations regarding its use in acute ill patients()
por: Valencia Gallardo, José Manuel, et al.
Publicado: (2022)

Challenges in understanding host genetics and severity of community-acquired pneumonia
por: Solé-Violán, Jordi, et al.
Publicado: (2021)

Red Blood Cell Distribution Width during the First Week Is Associated with Severity and Mortality in Septic Patients
por: Lorente, Leonardo, et al.
Publicado: (2014)

Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer
por: Zhang, Yangyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9mp21peqpdp1rbn6o8hqv76rhs